Related Experiment Video
Updated: Apr 21, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Intraocular bevacizumab for iris neovascularization in a silicone oil-filled eye
1From the Department of Ophthalmology, University of California at San Francisco, San Francisco, California.
Purpose:
To report the effectiveness of intravitreal injection of bevacizumab for treatment of iris neovascularization in a silicone oil-filled eye.
Design:
Case report.
Patient:
A 56-year-old man with recurrent retinal detachment associated with iris neovascularization.
Results:
Iris neovascularization regressed after treatment with a 1.25-mg intravitreal injection of bevacizumab in the presence of silicone oil.
Discussion:
Intraocular injection of bevacizumab is an effective short-term treatment of neovascularization caused by persistent retinal detachment even in the presence of silicone oil. The standard dose of 1.25 mg of bevacizumab may not require adjustment in an aphakic vitrectomized eye.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

